Zoetis stock lags market as analysts brace for earnings decline

Published on 09/19/2026 at 18:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zoetis stock recently closed at USD 71.40 on September 18, 2026, underperforming the broader market. Consensus now points to declining third-quarter EPS and revenue, keeping the shares under pressure ahead of the next earnings release.

ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis Inc. stock (ISIN US98978V1035) most recently closed at USD 71.40 on the New York Stock Exchange on September 18, 2026, marking a 2.22 percent drop that lagged the S&P 500’s 0.17 percent gain on the same day, according to Yahoo Finance.

Earnings expectations turn cautious

As Yahoo Finance reports, analysts currently project Zoetis to deliver third-quarter 2026 earnings per share of USD 1.52, which would represent a 10.59 percent decline compared with the same quarter a year earlier.

The same consensus expects third-quarter 2026 revenue of USD 2.31 billion, implying a 3.66 percent drop versus the corresponding quarter of the prior year, according to Yahoo Finance.

Full-year outlook and valuation signals

Looking at the full year 2026, consensus estimates compiled by Yahoo Finance point to earnings of USD 6.20 per share, down 3.28 percent from the previous year.

For revenue, the same overview indicates a full-year 2026 consensus of USD 9.24 billion, which would be 2.45 percent lower than the prior year, according to Yahoo Finance.

Analyst ratings and price targets

On the rating side, Stifel Nicolaus maintains a Hold recommendation on Zoetis stock, with a focus on near-term share concerns, according to Investing.com.

In the same note, Stifel sets a price target of USD 80.00 for Zoetis, compared with the recent closing level of USD 71.40, so the target implies upside of about 12 percent if the shares were to move from the latest price to that level, according to Investing.com.

Stock performance context

Over the last month, Zoetis stock has fallen 2.67 percent, missing out on a 0.65 percent gain in the broader medical sector while the S&P 500 index slipped 1.29 percent in the same period, according to Yahoo Finance.

Despite this weaker performance, Zoetis remains a major player in animal health, and investors are watching whether upcoming earnings can shift sentiment away from the current expectation of modest declines in both profit and revenue.

Stock price snapshot

Zoetis stock closed at USD 71.40 on the New York Stock Exchange on September 18, 2026, down 2.22 percent from the prior session and trading close to its recent 52-week low region, based on data cited by Yahoo Finance.